|
⚲
|
| Keyboard |
| Errik Anderson | |
|---|---|
| Firm | |
| Address | 3675 Market Street, Suite 200 Philadelphia, PA 19104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cantai Therapeutics Inc | 021-570571 | Executive Officer | 3.0 M of 3.0 M |
||
| Angiex Inc | 021-554765 | Director | 22.0 M of 28.4 M |
||
| Alumni Ventures Group LLC | 021-554563 | Director | 14.1 M of 25.0 M |
||
| Cantai Therapeutics Inc | 021-551755 | Executive Officer | 0.6 M of 1.1 M |
||
| Alumni Ventures Group LLC | 021-546046 | Director | 2.5 M of 15.0 M |
||
| Alumni Ventures Group LLC | 021-545973 | Director | 3.9 M of 25.0 M |
||
| Wheeler Bio Inc | 021-544523 | Director | 23.1 M of 36.5 M |
||
| Alumni Ventures Group LLC | 021-538388 | Director | 6.2 M of 20.0 M |
||
| Alumni Ventures Group LLC | 021-521622 | Director | 2.5 M of 25.0 M |
||
| Aakha Biologics Inc | 021-519031 | Director | 0.8 M of 5.0 M |
||
| Alumni Ventures Group LLC | 021-513368 | Director | 0.8 M of 10.0 M |
||
| Alumni Ventures Group LLC | 021-513367 | Director | 0.1 M of 10.0 M |
||
| Cantai Therapeutics Inc | 021-497690 | Executive Officer | 0.7 M of 30.0 M |
||
| Mytide Therapeutics Inc | 021-469965 | Director | 1.2 M of 2.5 M |
||
| Wheeler Bio Inc | 021-461220 | Director | 23.2 M of 30.0 M |
||
| Alloy Therapeutics Inc | 021-460478 | Executive Officer | 41.7 M of 41.7 M |
||
| Vernal Biosciences Inc | 021-446902 | Director | 41.0 M of 41.0 M |
||
| Mytide Therapeutics Inc | 021-430375 | Director | 7.1 M of 7.1 M |
||
| Wheeler Bio Inc | 021-422258 | Director | 13.6 M of 14.5 M |
||
| Vernal Biosciences Inc | 021-400356 | Director | 1.5 M of 1.5 M |
||
| Alloy Therapeutics Inc | 021-394522 | Executive Officer | 75.0 M of 75.0 M |
||
| UDH MSPV II LLC | 021-321302 | Executive Officer | 0.0 M | ||
| Compass Therapeutics LLC | 021-302629 | Director | 21.8 M of 50.0 M |
||
| UDH MSPV I LLC | 021-297474 | Executive Officer | 0.2 M | ||
| GTP AW Fund II LLC | 021-271033 | Executive Officer | 1.1 M of 2.6 M |
||
| Compass Therapeutics LLC | 021-242888 | Director | 110.2 M of 170.2 M |
||
| Compass Therapeutics LLC | 021-219210 | Executive Officer | 0.6 M of 1.0 M |
||
| Avitide Inc | 021-218775 | Director | 3.4 M of 3.4 M |
||
| Arsanis Inc | 021-201235 | Executive Officer | 20.0 M of 20.0 M |
||
| Avitide Inc | 021-193359 | Director | 1.4 M of 1.4 M |
||
| Adimab LLC | 021-176042 | Executive Officer | 13.8 M of 13.8 M |
||
| Arsanis Inc | 021-154945 | Executive Officer | 9.6 M of 9.6 M |
||
| Adimab Inc | 021-151089 | Executive Officer | 4.0 M of 4.0 M |
||
| Arsanis Inc | 021-148139 | Executive Officer | 0.4 M of 0.4 M |
||
| Adimab Inc | 021-106179 | Executive Officer | 8.2 M of 8.2 M |
||
| 82VS Management LLC | |||||
| 82VS Seed Fund I LP | 021-505014 | Executive Officer | 0.1 M | ||
| 82VS Seed Fund LP | 021-505012 | Executive Officer | 20.0 M of 20.0 M |
14.2 M | |
| Alumni Ventures LLC | |||||
| Green D Founders Fund 2014-I LLLP | 021-233022 | Executive Officer | 1.2 M of 10.0 M |
2.1 M | |
| Related People Network |
|---|
| Network #459 at Arsanis Inc — files alongside 2 co-filers |